ArticleMaterials today. Bio2025
GM@mTG-V microspheres promote NP regeneration by reconstructing IVD biomechanics and inflammatory microenvironment.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Smart functionalized cartilage repair microspheres: Concepts and applications.Materials today. Bio · 2026Review
- Notch signaling-targeted biomimetic hydrogel constructs an anti-inflammatory "flood-control" system to alleviate pyroptosis for intervertebral disc degeneration treatment.Materials today. Bio · 2026Article
- Mechanomedicine in digestive surgery: a theranostic framework integrating mechanical diagnostics and therapeutic modulation across the perioperative continuum.Theranostics · 2026Review
- miR-191-5p attenuates TNF-α-induced inflammation in nucleus pulposus cells via targeting EGR1.Journal of orthopaedic surgery and research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intervertebral disc degeneration (IVDD) has emerged as a significant global public health challenge, imposing substantial burdens on both individuals and society. Growing evidence suggests that modulating the mechanical microenvironment and alleviating inflammation in degenerated IVDs can promote tissue regeneration. In this study, we integrated natural pharmaceuticals with tissue engineering strategies to develop functionalized microspheres (GM@mTG-V) through microfluidic synthesis, where vanillin - a natural compound with anti-inflammatory and antioxidant properties - was polymerized with gelatin methacryloyl (GelMA, composed of gelatin derived from methyl acrylamide and methacrylate groups). In vitro, the functionalized microspheres not only enhanced vanillin release efficiency but also effectively suppressed inflammatory responses and oxidative stress in nucleus pulposus (NP) cells. By dynamically regulating matrix stiffness, these microspheres could remodel the mechanical microenvironment of degenerated IVD, significantly promoting extracellular matrix (ECM) secretion. In vivo, both 4 week and 8 week IVDD models demonstrated that GM@mTG-V markedly reduced tissue inflammation, accelerated ECM accumulation, and restored IVD structure, as confirmed by radiographic and histological analyses. This study verifies that GM@mTG-V promotes regeneration of degenerated IVD through dual mechanisms: stabilizing mechanical matrix stiffness and suppressing inflammatory microenvironments, providing a novel and promising therapeutic strategy for early stage IVDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.